Ceryvyn Therapeutics Limited (ASX: CYV)
Sector: Health Care
Market cap: A$14M (as of 2 Nov 2026)
Ceryvyn Therapeutics is a clinical-stage biopharmaceutical company developing innovative therapies by translating advances in human biology into transformative medicines for patients with serious diseases. The Company seeks to identify biological mechanis
Data as of 2 Nov 2026.
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 13 Oct 2026 | JAGEN NOMINEES PTY LTD AND ITS RELEVANT ENTITIES (ANNEXURE A) | Increase | 16.53% → 19.17% | Filing ↗ |
| 8 Oct 2026 | JAGEN NOMINEES PTY LTD AND ITS RELEVANT ENTITIES | Increase | 12.45% → 16.56% | Filing ↗ |
| 6 Oct 2026 | JAGEN MORRNCER ATY LTO AND | Entry | ?% → 10.7% | Filing ↗ |
| 2 Oct 2026 | JAGCN NOMINEES PTY LTD AND ITS RELEVANT ENTITIES (ANNEXURE A) | Increase | 9.66% → 10.76% | Filing ↗ |
Cash and runway
Ask about CYV in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has CYV raised money in the last year, and at what discount?
- What was CYV's latest cash position and runway?
Loading CYV…